表紙
市場調查報告書

抗憂鬱症藥的全球市場

Antidepressants

出版商 Global Industry Analysts, Inc. 商品編碼 912431
出版日期 內容資訊 英文 272 Pages
商品交期: 最快1-2個工作天內
價格
抗憂鬱症藥的全球市場 Antidepressants
出版日期: 2020年02月01日內容資訊: 英文 272 Pages
簡介

本報告提供全球抗憂鬱症藥市場概要,提供趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及各地區·主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球抗憂鬱症藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ALLERGAN PLC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • H. LUNDBECK A/S
  • MERCK & CO., INC.
  • OTSUKA AMERICA PHARMACEUTICAL
  • PFIZER
  • 武田藥品工業
  • TEVA PHARMACEUTICAL INDUSTRIES

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1383

Antidepressants market worldwide is projected to grow by US$2.4 Billion, driven by a compounded growth of 2.3%. Major Depressive Disorder, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6.5 Billion by the year 2025, Major Depressive Disorder will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$94.9 Million to the region's size and clout in the next 5 to 6 years. Over US$69.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Major Depressive Disorder will reach a market size of US$400.5 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$659.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Allergan PLC
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Merck & Co., Inc.
  • Otsuka America Pharmaceutical, Inc.
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • An Introduction to Antidepressants
  • An Introduction to Types of Disorders
  • Types of Antidepressants
  • A Prelude to Antidepressants Market
  • Major Depressive Disorder: Market Overview
  • Obsessive-Compulsive Disorder: Market Overview
  • Generalized Anxiety Disorder: Market Overview
  • Panic Disorder: Market Overview
  • North America Antidepressants Market
  • Asia-Pacific Antidepressants Market
  • Europe Antidepressants Market
  • Major Depressive Disorder Dominates the Market Segment
  • Infographics
  • Global Competitor Market Shares
  • Market Share by Key Players
  • Market Share by Mental Health or Substance Use Disorders
  • Market Share by Region
  • Antidepressants Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Trends in Anxiety and Panic Disorders Drugs Market
  • Increasing Prevalence of Depression Among All Sections of Individuals is Enabling the Market Growth
  • Substance Abuse Likely to Increase the Risk of Mental Disorders
  • Various Factors Causing Mental Illness
  • Challenges in Using Antidepressants
  • Latest Advances in Antidepressants Market

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Antidepressants Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Antidepressants Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Antidepressants Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Major Depressive Disorder (Disorder) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Major Depressive Disorder (Disorder) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Major Depressive Disorder (Disorder) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Obsessive-Compulsive Disorder (Disorder) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Obsessive-Compulsive Disorder (Disorder) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Obsessive-Compulsive Disorder (Disorder) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Generalized Anxiety Disorder (Disorder) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Generalized Anxiety Disorder (Disorder) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Generalized Anxiety Disorder (Disorder) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Panic Disorder (Disorder) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Panic Disorder (Disorder) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Panic Disorder (Disorder) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Other Disorders (Disorder) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Other Disorders (Disorder) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Other Disorders (Disorder) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Tricyclic Antidepressants (Product) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Tricyclic Antidepressants (Product) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Tricyclic Antidepressants (Product) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Selective Serotonin Reuptake Inhibitors (Product) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Selective Serotonin Reuptake Inhibitors (Product) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Selective Serotonin Reuptake Inhibitors (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Serotonin-Norepinephrine Reuptake Inhibitors (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Serotonin-Norepinephrine Reuptake Inhibitors (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Serotonin-Norepinephrine Reuptake Inhibitors (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Monoamine Oxidase Inhibitors (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 29: Monoamine Oxidase Inhibitors (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 30: Monoamine Oxidase Inhibitors (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 31: Serotonin Antagonist & Reuptake Inhibitors (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 32: Serotonin Antagonist & Reuptake Inhibitors (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 33: Serotonin Antagonist & Reuptake Inhibitors (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: Other Products (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 35: Other Products (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 36: Other Products (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Antidepressants Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 37: United States Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025
    • TABLE 38: Antidepressants Market in the United States by Disorder: A Historic Review in US$ Million for 2009-2017
    • TABLE 39: United States Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 40: United States Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 41: Antidepressants Market in the United States by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 42: United States Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 43: Canadian Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025
    • TABLE 44: Canadian Antidepressants Historic Market Review by Disorder in US$ Million: 2009-2017
    • TABLE 45: Antidepressants Market in Canada: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025
    • TABLE 46: Canadian Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 47: Canadian Antidepressants Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 48: Antidepressants Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
  • JAPAN
    • TABLE 49: Japanese Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025
    • TABLE 50: Antidepressants Market in Japan: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017
    • TABLE 51: Japanese Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 52: Japanese Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 53: Antidepressants Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 54: Japanese Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 55: Chinese Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025
    • TABLE 56: Antidepressants Historic Market Analysis in China in US$ Million by Disorder: 2009-2017
    • TABLE 57: Chinese Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 58: Chinese Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 59: Antidepressants Historic Market Analysis in China in US$ Million by Product: 2009-2017
    • TABLE 60: Chinese Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Antidepressants Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 61: European Antidepressants Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 62: Antidepressants Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 63: European Antidepressants Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: European Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025
    • TABLE 65: Antidepressants Market in Europe in US$ Million by Disorder: A Historic Review for the Period 2009-2017
    • TABLE 66: European Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 67: European Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 68: Antidepressants Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 69: European Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 70: Antidepressants Market in France by Disorder: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 71: French Antidepressants Historic Market Scenario in US$ Million by Disorder: 2009-2017
    • TABLE 72: French Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 73: Antidepressants Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 74: French Antidepressants Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 75: French Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 76: Antidepressants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025
    • TABLE 77: German Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017
    • TABLE 78: German Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 79: Antidepressants Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 80: German Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 81: German Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 82: Italian Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025
    • TABLE 83: Antidepressants Historic Market Analysis in Italy in US$ Million by Disorder: 2009-2017
    • TABLE 84: Italian Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 85: Italian Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 86: Antidepressants Historic Market Analysis in Italy in US$ Million by Product: 2009-2017
    • TABLE 87: Italian Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 88: United Kingdom Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025
    • TABLE 89: Antidepressants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017
    • TABLE 90: United Kingdom Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 91: United Kingdom Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 92: Antidepressants Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 93: United Kingdom Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 94: Spanish Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025
    • TABLE 95: Spanish Antidepressants Historic Market Review by Disorder in US$ Million: 2009-2017
    • TABLE 96: Antidepressants Market in Spain: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025
    • TABLE 97: Spanish Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 98: Spanish Antidepressants Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 99: Antidepressants Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 100: Russian Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025
    • TABLE 101: Antidepressants Market in Russia by Disorder: A Historic Review in US$ Million for 2009-2017
    • TABLE 102: Russian Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 103: Russian Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 104: Antidepressants Market in Russia by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 105: Russian Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025
    • TABLE 107: Antidepressants Market in Rest of Europe in US$ Million by Disorder: A Historic Review for the Period 2009-2017
    • TABLE 108: Rest of Europe Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 109: Rest of Europe Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 110: Antidepressants Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 111: Rest of Europe Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 112: Asia-Pacific Antidepressants Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 113: Antidepressants Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 114: Asia-Pacific Antidepressants Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 115: Antidepressants Market in Asia-Pacific by Disorder: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 116: Asia-Pacific Antidepressants Historic Market Scenario in US$ Million by Disorder: 2009-2017
    • TABLE 117: Asia-Pacific Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 118: Antidepressants Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 119: Asia-Pacific Antidepressants Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 120: Asia-Pacific Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 121: Antidepressants Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025
    • TABLE 122: Australian Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017
    • TABLE 123: Australian Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 124: Antidepressants Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 125: Australian Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 126: Australian Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 127: Indian Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025
    • TABLE 128: Indian Antidepressants Historic Market Review by Disorder in US$ Million: 2009-2017
    • TABLE 129: Antidepressants Market in India: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025
    • TABLE 130: Indian Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 131: Indian Antidepressants Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 132: Antidepressants Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 133: Antidepressants Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025
    • TABLE 134: South Korean Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017
    • TABLE 135: Antidepressants Market Share Distribution in South Korea by Disorder: 2009 VS 2019 VS 2025
    • TABLE 136: Antidepressants Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 137: South Korean Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 138: Antidepressants Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 139: Rest of Asia-Pacific Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025
    • TABLE 140: Antidepressants Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017
    • TABLE 141: Rest of Asia-Pacific Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 142: Rest of Asia-Pacific Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 143: Antidepressants Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 144: Rest of Asia-Pacific Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 145: Latin American Antidepressants Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 146: Antidepressants Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 147: Latin American Antidepressants Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 148: Latin American Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025
    • TABLE 149: Antidepressants Historic Market Analysis in Latin America in US$ Million by Disorder: 2009-2017
    • TABLE 150: Latin American Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 151: Latin American Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 152: Antidepressants Historic Market Analysis in Latin America in US$ Million by Product: 2009-2017
    • TABLE 153: Latin American Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 154: Argentinean Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025
    • TABLE 155: Antidepressants Market in Argentina in US$ Million by Disorder: A Historic Review for the Period 2009-2017
    • TABLE 156: Argentinean Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 157: Argentinean Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 158: Antidepressants Market in Argentina in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 159: Argentinean Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 160: Antidepressants Market in Brazil by Disorder: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 161: Brazilian Antidepressants Historic Market Scenario in US$ Million by Disorder: 2009-2017
    • TABLE 162: Brazilian Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 163: Antidepressants Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 164: Brazilian Antidepressants Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 165: Brazilian Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 166: Antidepressants Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025
    • TABLE 167: Mexican Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017
    • TABLE 168: Mexican Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 169: Antidepressants Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 170: Mexican Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 171: Mexican Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 172: Rest of Latin America Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025
    • TABLE 173: Antidepressants Market in Rest of Latin America by Disorder: A Historic Review in US$ Million for 2009-2017
    • TABLE 174: Rest of Latin America Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 175: Rest of Latin America Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 176: Antidepressants Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 177: Rest of Latin America Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 178: The Middle East Antidepressants Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 179: Antidepressants Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 180: The Middle East Antidepressants Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 181: The Middle East Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018 to 2025
    • TABLE 182: The Middle East Antidepressants Historic Market by Disorder in US$ Million: 2009-2017
    • TABLE 183: Antidepressants Market in the Middle East: Percentage Share Breakdown of Sales by Disorder for 2009, 2019, and 2025
    • TABLE 184: The Middle East Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 185: The Middle East Antidepressants Historic Market by Product in US$ Million: 2009-2017
    • TABLE 186: Antidepressants Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
  • IRAN
    • TABLE 187: Iranian Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Disorder for the Period 2018-2025
    • TABLE 188: Antidepressants Market in Iran: Historic Sales Analysis in US$ Million by Disorder for the Period 2009-2017
    • TABLE 189: Iranian Antidepressants Market Share Analysis by Disorder: 2009 VS 2019 VS 2025
    • TABLE 190: Iranian Market for Antidepressants: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 191: Antidepressants Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 192: Iranian Antidepressants Market Share Analysis by Product: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 193: Israeli Antidepressants Market Estimates and Forecasts in US$ Million by Disorder: 2018-2025
    • TABLE 194: Antidepressants Market in Israel in US$ Million by Disorder: A Historic Review for the Period 2009-2017
    • TABLE 195: Israeli Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 196: Israeli Antidepressants Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 197: Antidepressants Market in Israel in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 198: Israeli Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 199: Saudi Arabian Antidepressants Market Growth Prospects in US$ Million by Disorder for the Period 2018-2025
    • TABLE 200: Antidepressants Historic Market Analysis in Saudi Arabia in US$ Million by Disorder: 2009-2017
    • TABLE 201: Saudi Arabian Antidepressants Market by Disorder: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 202: Saudi Arabian Antidepressants Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 203: Antidepressants Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2009-2017
    • TABLE 204: Saudi Arabian Antidepressants Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 205: Antidepressants Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025
    • TABLE 206: United Arab Emirates Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017
    • TABLE 207: Antidepressants Market Share Distribution in United Arab Emirates by Disorder: 2009 VS 2019 VS 2025
    • TABLE 208: Antidepressants Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 209: United Arab Emirates Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 210: Antidepressants Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 211: Antidepressants Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disorder for the Period 2018-2025
    • TABLE 212: Rest of Middle East Antidepressants Historic Market Analysis in US$ Million by Disorder: 2009-2017
    • TABLE 213: Rest of Middle East Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 214: Antidepressants Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 215: Rest of Middle East Antidepressants Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 216: Rest of Middle East Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 217: African Antidepressants Market Estimates and Projections in US$ Million by Disorder: 2018 to 2025
    • TABLE 218: Antidepressants Market in Africa by Disorder: A Historic Review in US$ Million for 2009-2017
    • TABLE 219: African Antidepressants Market Share Breakdown by Disorder: 2009 VS 2019 VS 2025
    • TABLE 220: African Antidepressants Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 221: Antidepressants Market in Africa by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 222: African Antidepressants Market Share Breakdown by Product: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ALLERGAN PLC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • H. LUNDBECK A/S
  • MERCK & CO., INC.
  • OTSUKA AMERICA PHARMACEUTICAL
  • PFIZER
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH